BRPI1011507A2 - alpha4-beta-7 heterodimer specific antagonist antibody - Google Patents
alpha4-beta-7 heterodimer specific antagonist antibodyInfo
- Publication number
- BRPI1011507A2 BRPI1011507A2 BRPI1011507A BRPI1011507A BRPI1011507A2 BR PI1011507 A2 BRPI1011507 A2 BR PI1011507A2 BR PI1011507 A BRPI1011507 A BR PI1011507A BR PI1011507 A BRPI1011507 A BR PI1011507A BR PI1011507 A2 BRPI1011507 A2 BR PI1011507A2
- Authority
- BR
- Brazil
- Prior art keywords
- alpha4
- beta
- antagonist antibody
- specific antagonist
- heterodimer specific
- Prior art date
Links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16215409P | 2009-03-20 | 2009-03-20 | |
US20682910P | 2010-02-22 | 2010-02-22 | |
PCT/US2010/027422 WO2010107752A2 (en) | 2009-03-20 | 2010-03-16 | Alpha-4-beta-7 heterodimer specific antagonist antibody |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI1011507A2 true BRPI1011507A2 (en) | 2016-03-22 |
Family
ID=55534018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1011507A BRPI1011507A2 (en) | 2009-03-20 | 2010-03-16 | alpha4-beta-7 heterodimer specific antagonist antibody |
Country Status (1)
Country | Link |
---|---|
BR (1) | BRPI1011507A2 (en) |
-
2010
- 2010-03-16 BR BRPI1011507A patent/BRPI1011507A2/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2022023I2 (en) | CGRP RECEPTOR COMPETITORS | |
LTPA2019011I1 (en) | CGRP antibodies | |
IL239965A0 (en) | Alpha-4-beta-7 heterodimer specific antagonist antibody | |
BR112012030311A2 (en) | antibody | |
SMT201700083B (en) | MONOCLONAL ANTIBODIES | |
DK2821407T3 (en) | PIPERIDINONCARBOXAMIDAZAINDAN-CGRP RECEPTOR ANTAGONISTS | |
DK2483310T3 (en) | BISPECIFIC DEATH RECEPTOR AGONISTIC ANTIBODIES | |
BRPI1006519A2 (en) | antibody formulation | |
BRPI0907237A2 (en) | Anti-cldn6 antibody | |
BRPI1014262A2 (en) | cadherin-17 specific antibodies | |
DK2443104T3 (en) | DISUBSTITUTED PHTHALAZINE-HEDGEHOG-STI ANTAGONISTS | |
CO6791565A2 (en) | Anti-notch1 antibodies | |
BR112013008833A2 (en) | pipe claw mechanism | |
BR112012003976A2 (en) | carbocyclic glyt1 receptor antagonists | |
BRPI0908008A2 (en) | Dual Pharmacophore - pde4-muscarinic antagonists | |
BRPI1006514A2 (en) | gm-csf antagonist | |
FI9382U1 (en) | pylon | |
BRPI0907519A2 (en) | Dual-pde4-muscarinic pharmacophor antagonists | |
ES1071355Y (en) | ANTISISMIC DEVICE FOR BUILDINGS | |
BR112012011093A2 (en) | antigens for actinobacillus suis | |
BRPI1011507A2 (en) | alpha4-beta-7 heterodimer specific antagonist antibody | |
BR112012005119A2 (en) | new hepcidine ethanodiamin antagonists | |
ES1070237Y (en) | "ANTISEISM DEVICE FOR CONSTRUCTION" | |
ES1070148Y (en) | IMPROVED BARROT MACOLLA | |
ES1070021Y (en) | IMPROVED CONSTRUCTION ANCHOR |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS. |
|
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |